Cargando…

Preclinical animal models of COPD

Detalles Bibliográficos
Autor principal:	Vlahos, Ross
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750936/ http://dx.doi.org/10.1186/1476-9255-10-S1-P25

Ejemplares similares

1072. Red blood cell transfusion in acute cerebral injuries: a systematic review of preclinical animal studies
por: Laflamme, M, et al.
Publicado: (2014)

A mouse GITRl fusion protein drives T cell activation and antitumor activity in preclinical mouse models of cancer
por: Leyland, Rebecca, et al.
Publicado: (2015)

Recent advances in pre-clinical mouse models of COPD
por: Vlahos, Ross, et al.
Publicado: (2013)

Optimizing the delivery of chemotherapy in the setting of immunotherapy in a preclinical glioblastoma model
por: Mathios, Dimitrios, et al.
Publicado: (2015)

Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo
por: Stewart, Ross, et al.
Publicado: (2014)

Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011)

Preclinical evaluation of MVA-MUC1-IL2 in combination with chemotherapy in murine models
por: De Meyer, Micaël, et al.
Publicado: (2013)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

The importance of antibiotics in animal models of sepsis
por: Maybauer, MO, et al.
Publicado: (2005)

PRF thermometry during MR-guided focused ultrasound ablation in a preclinical thiel model
por: Karakitsios, Ioannis, et al.
Publicado: (2015)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models
por: O'Connor, JPB, et al.
Publicado: (2015)

Cyclophosphamide mechanism of action in preclinical tecemotide studies
por: Hance, Ken, et al.
Publicado: (2013)

Lost in translation? Bridging the preclinical / clinical divide
por: Baker, Mark, et al.
Publicado: (2012)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Honey as an immunomodulator during sepsis in animal model
por: Kassim, M, et al.
Publicado: (2009)

Tethered cord - a new animal model
por: Clemmensen, Dorte, et al.
Publicado: (2009)

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
por: Schlerman, F, et al.
Publicado: (2013)

Modulation of immune cell infiltrate with sunitinib to improve anti-PD1 therapy in preclinical tumor model
por: Rayman, Patricia, et al.
Publicado: (2015)

Advancements in preclinical screening methods for artemisinins during pregnancy
por: Donegan, G, et al.
Publicado: (2010)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Hypophosphatemia of prognostic value in acute exacerbation of COPD
por: Makhoul, N, et al.
Publicado: (2011)

Preclinical test of a lentivirus-mediated RNAi gene therapy against HIV-AIDS in the humanized mouse model
por: Centlivre, Mireille, et al.
Publicado: (2011)

Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
por: Bao, Xingfeng, et al.
Publicado: (2015)

Hemorrhage contributes to chronic adverse remodeling in acute myocardial infarction: Insights from a novel preclinical model
por: Ghugre, Nilesh R, et al.
Publicado: (2015)

Effects of URB937 on an animal model of migraine pain
por: Greco, R, et al.
Publicado: (2013)

P-8 Preclinical Cardiac Involvement In Progressive External Ophthalmoplegia
por: Franzoni, F., et al.
Publicado: (2011)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer
por: Hay, T, et al.
Publicado: (2008)

A mouse model of acute exacerbations of lung inflammation in COPD with both steroid-sensitive and steroid-insensitive features
por: Russell, V, et al.
Publicado: (2013)

Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
por: Alexandre, Pedro CB, et al.
Publicado: (2013)

Clinical severity and local inflammatory responses in animal models of sepsis
por: Saeed, S, et al.
Publicado: (2010)

Head-up tilt and passive leg raising in healthy volunteers as a preclinical model for preload-induced stroke volume modification
por: Lima, A, et al.
Publicado: (2009)

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
por: Foy, Susan P, et al.
Publicado: (2014)

Latter-stage preclinical developmental work on PL69/DM1157
por: Peyton, David
Publicado: (2014)

Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma
por: Toomey, Ngoc, et al.
Publicado: (2015)

Mechanism of tau transfer: insights from cell culture and animal models
por: Wu, Jessica, et al.
Publicado: (2013)

P01.43. The calm mouse: an animal model of stress reduction
por: Gurfein, B, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8jc3aeujabkt9ieb09pkts3bqe